Related Experiment Videos
Moderately hypofractionated breast radiation therapy: is more evidence needed? - Authors' reply
1State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
The Lancet. Oncology
|May 3, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prognostic and Treatment Values of Baseline Metabolic Tumor Volume in Early-stage Extranodal NK/T-cell Lymphoma in the Modern Treatment Era.
International journal of radiation oncology, biology, physics·2026
Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Extranodal natural killer/T-cell lymphoma: From fatal to curable.
CA: a cancer journal for clinicians·2026
Persistent Colonic Activity on 99mTc-MDP Whole Bone Scintigraphy Revealing a Complex Ureterorectal Fistula.
Clinical nuclear medicine·2026
Dynamic and Structural Retinal Microvascular Alterations After Radiation Exposure: Insights From a Large-Animal Model.
Investigative ophthalmology & visual science·2026
Multiple Radioiodine-avid Skin Metastases From Thyroid Carcinoma Detected on Posttherapy 131I SPECT/CT.
Clinical nuclear medicine·2026
A Dual GSH/ROS-Functional NIR Fluorescent Platform for Synergistic Photodynamic Therapy and Radiosensitization in Nasopharyngeal Carcinoma.
Small (Weinheim an der Bergstrasse, Germany)·2026